🇫🇷 France Country × Condition
healthy volunteers Clinical Trials in France
Active clinical trials for healthy volunteers with research sites in France. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇫🇷 France
Active Trials in France (5)
NCT05698810
Recruiting
Preparation and Feasibility of Exams for Expected Studies
Enrollment
150 pts
Country
🇫🇷 France
University Hospital, Grenoble
View Trial → NCT04457622
Recruiting
Language and Brain Rhythms
Enrollment
356 pts
Country
🇫🇷 France
Hospices Civils de Lyon
View Trial → NCT03807401
Recruiting
A Technical Innovation of Prismatic Adaptation Test in Healthy Subject, in Favour of Autonomy and Independence in Daily Life Following a Brain Injury
Enrollment
480 pts
Country
🇫🇷 France
Hospices Civils de Lyon
View Trial → NCT07145970
Recruiting
Standardization of Spatial Neglect Assessment Tests
Enrollment
210 pts
Country
🇫🇷 France
Assistance Publique - Hôpitaux de P...
View Trial → NCT06481306 Phase 1, Phase 2
Recruiting
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
Enrollment
184 pts
Country
🇫🇷 France
Bristol-Myers Squibb
View Trial → Frequently Asked Questions
How many healthy volunteers clinical trials are active in France?
There are currently 5 active clinical trials for healthy volunteers with sites in France, of which 5 are actively recruiting patients.
How can I join a healthy volunteers clinical trial in France?
To join a healthy volunteers clinical trial in France, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in France directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are healthy volunteers trials in France?
Active healthy volunteers trials in France span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.